Korean J Helicobacter Up Gastrointest Res > Volume 21(3); 2021 > Article |
|
Study | Number of lesions | PEB (%) | Risk factors (multivariate analysis) |
---|---|---|---|
Takahashi et al. [45] (2014) | 459 | 5.0 | Younger age, lesions in the lower segment, large size of the resected specimen |
Nakamura et al. [46] (2012) | 544 | 7.0 | Low platelet count (<150×109/L), and positive or indeterminate lateral margin |
Yano et al. [6] (2017) | 1,767 | 8.5 | Lesions at the distal stomach, procedure time ≥90 minutes, specimen size ≥4 cm, antithrombotic therapy |
Toyokawa et al. [47] (2012) | 1,123 | 5.0 | Aged ≥80 years, a long procedure time |
Koh et al. [5] (2013) | 1,192 | 5.3 | Specimen size >4 cm |
Sanomura et al. [48] (2018) | 1,243 | 4.1 | Dialysis, anticoagulant (warfarin and heparin replacement/DOAC), operation time ≥75 minutes |
Matsumura et al. [11] (2014) | 425 | 4.7 | Heparin replacement, CKD undergoing, hemodialysis, specimen size ≥4 cm |
Ebi et al. [49] (2014) | 186 | 4.2 | Hypertension, depressed-type tumors |
Miyahara et al. [50] (2012) | 1,190 | 6.9 | Tumor location, resected tumor size, scarring in lesion |
Kim et al. [32] (2014) | 441 | 4.1 | Large tumor size (>2 cm) |
Libânio et al. [31] (2016)a | 62 studies | 5.1 | Male sex, cardiopathy, antithrombotic drugs, cirrhosis, chronic kidney disease, tumor size >20 mm, resected specimen size >30 mm, localization in the lesser curvature, flat/depressed morphology, carcinoma histology, ulceration, procedure duration >60 minutes, the use of histamine-2 receptor antagonists instead of proton pump inhibitors |
Choe et al. [14] (2021) | 5,080 | 5.1 | Ongoing antithrombotics during procedure, cancer pathology on biopsy, piecemeal resection |
Hatta et al. [51] (2021) | 8,291 | 4.7 | CKD with hemodialysis, aspirin, P2Y12RA, cilostazol, warfarin, DOAC, interruption of agents, multiple tumors, tumor size >30 mm, lower third location |
Study | Methods | Study design | N | Enrolled patients characteristics | Overall post-ESD bleeding |
---|---|---|---|---|---|
Takizawa et al. [27] (2008) | Preventive coagulation of visible vessels | Retrospective | 968 | Do not consider specific factors | Study 52/680 (7.1%) |
Control 11/340 (3.1%) | |||||
Uedo et al. [28] (2010) | Doppler endoscopic ultrasound | Case series | 10 | Do not consider specific factors | 0 (0.0%) |
Mukai et al. [29] (2013) | Preventive coagulation plus artery-selective clipping | Retrospective | 234 | Do not consider specific factors | Study 1/80 (1.3%) |
Control 7/154 (4.5%) | |||||
Ikeda et al. [33] (2020) | Third-look endoscopy | Phase II trial | 96 | Taking with antithrombotics | Study 6/58 (10.3%) |
Control 12/58 (20.7%) | |||||
Lee et al. [34] (2011) | Detachable snare and clips | RCT | 52 | Do not consider specific factors | Study 1/26 (4.0%) |
Control 0 (0.0%) | |||||
Kantsevoy et al. [35] (2014) | Overstitch endoscopic suturing device | Retrospective | 12 | Do not consider specific factors | 0 (0.0%) |
Tsuji et al. [36] (2015) | Polyglycolic acid sheets and fibrin glue | Nonrandomized trial with historical control | 45 | Do not consider specific factors | Study 3/45 (6.7%) |
Control 9/41 (22.0%) | |||||
Kawata et al. [37] (2018) | Polyglycolic acid sheets and fibrin glue | Retrospective | 84 | Taking with antithrombotics | Study 3/52 (5.8%) |
Control 11/53 (20.8%) | |||||
Pioche et al. [39] (2016) | Self-assembling matrix-forming gel | Retrospective | 22 | Do not consider specific factors | 0 (0.0%) |
Jung et al. [44] (2020) | Hemostatic powder | RCT | 143 | Taking with antithrombotics or resected specimen size was expected to be >40 mm | Study 4/73 (5.5%) |
Control 7/50 (7.1%) |
Gastric Inverted Hyperplastic Polyp Removed Using Endoscopic Submucosal Dissection2023 March;23(1)
Subepithelial Tumor Diagnosed after Endoscopic Submucosal Dissection2022 December;22(4)
A Novel Knife for Endoscopic Submucosal Dissection in Early Gastric Cancer2022 March;22(1)
Atypical Scar Patterns after Gastric Endoscopic Submucosal Dissection2021 March;21(1)